ResearcherPusan National UniversityActive in the last 2 years
Sae-Ock Oh
Matched on ORCID iD 0000-0002-9365-7831; OpenAlex author ID A5070703096.
Their work
- Papers
- 6 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2018: 1 paper · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 6
- Recycling machinery of integrin coupled with focal adhesion turnover via RAB11-UNC13D-FAK axis for migration of pancreatic cancer cells. Last author DOI 10.1186/s12967-024-05630-9↗
- The Prognostic Significance and Tumor-promoting Roles of MED30 in Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-31394/v1↗
- Prognostic Significance of EIF4G1 in Patients with Pancreatic Ductal Adenocarcinoma Last author DOI 10.20944/preprints201901.0155.v1↗
- Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.2147/ott.s202101↗
- Evaluation of the prognostic significances of γ-secretase genes in pancreatic cancer. Co-author DOI 10.3892/ol.2019.10113↗
- ALKBH5 gene is a novel biomarker that predicts the prognosis of pancreatic cancer: A retrospective multicohort study. Co-author DOI 10.14701/ahbps.2018.22.4.305↗
Closest collaborators
The 7 strongest of 7 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yun Hak Kim · 6 shared papers, 2018–2024
- Paper Recycling machinery of integrin coupled with focal adhesion turnover via RAB11-UNC13D-FAK axis for migration of pancrea… DOI 10.1186/s12967-024-05630-9↗
- Paper The Prognostic Significance and Tumor-promoting Roles of MED30 in Pancreatic Cancer DOI 10.21203/rs.3.rs-31394/v1↗
- Paper Prognostic Significance of EIF4G1 in Patients with Pancreatic Ductal Adenocarcinoma DOI 10.20944/preprints201901.0155.v1↗
- Van-Thanh Duong · 1 shared paper, 2024
- Tae Sik Goh · 2 shared papers, 2019
- Liangwen Liu · 1 shared paper, 2020
- Sung Hoon Kim · 1 shared paper, 2019
- Yun Jeon · 1 shared paper, 2019
- Sung Hwan Cho · 1 shared paper, 2018
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.